2.18
Schlusskurs vom Vortag:
$2.08
Offen:
$2.03
24-Stunden-Volumen:
39,985
Relative Volume:
0.02
Marktkapitalisierung:
$7.17M
Einnahmen:
$8,700
Nettoeinkommen (Verlust:
$-8.49M
KGV:
-0.4422
EPS:
-4.9303
Netto-Cashflow:
$-7.39M
1W Leistung:
-8.79%
1M Leistung:
-13.15%
6M Leistung:
-32.51%
1J Leistung:
-30.13%
Heartsciences Inc Stock (HSCS) Company Profile
Firmenname
Heartsciences Inc
Sektor
Branche
Telefon
682-237-7781
Adresse
550 RESERVE ST, SUITE 360, SOUTHLAKE
Compare HSCS vs ABT, SYK, MDT, BSX, EW
| Aktien | Preis | Marktkapitalisierung | Umsatz | Nettogewinn | Free Cashflow | ENV |
|---|---|---|---|---|---|---|
|
HSCS
Heartsciences Inc
|
2.18 | 8.32M | 8,700 | -8.49M | -7.39M | -4.9303 |
|
ABT
Abbott Laboratories
|
105.74 | 182.00B | 46.59B | 5.41B | 7.38B | 3.0938 |
|
SYK
Stryker Corp
|
325.74 | 129.09B | 25.27B | 3.34B | 4.57B | 8.6334 |
|
MDT
Medtronic Plc
|
85.40 | 107.81B | 36.36B | 4.84B | 5.43B | 3.7261 |
|
BSX
Boston Scientific Corp
|
46.73 | 67.64B | 20.62B | 3.56B | 3.48B | 2.3847 |
|
EW
Edwards Lifesciences Corp
|
86.03 | 47.81B | 6.30B | 1.07B | 1.09B | 1.8406 |
Heartsciences Inc Aktie (HSCS) Neueste Nachrichten
Fortitude Mining activates Nebraska facility, eyes public listing through HeartSciences merger - Crypto Briefing
New Nebraska facility takes Fortitude power portfolio past 60 MW - Stock Titan
HeartSciences (NASDAQ: HSCS) sets up Fortitude Mining reverse merger, major dilution - Stock Titan
HeartSciences Inc (HSCS) Revenue Breakdown: Business Segments, Regional Revenue & Profit Contribution - TradingKey
HeartSciences Amends Merger Agreement With Fortitude Mining - TipRanks
HeartSciences (NASDAQ: HSCS) reveals Fortitude crypto mining results - Stock Titan
HeartSciences Inc (HSCS) Dividends & Stock Splits: Historical Payouts and Event Timeline - TradingKey
HeartSciences Inc (HSCS) Cash Flow - TradingKey
TradingKey - TradingKey
HeartSciences Inc. Revenue Breakdown – BOATS:HSCS - TradingView
HeartSciences Inc (HSCS) Shareholder Structure: Major Shareholders & Institutional Holdings - TradingKey
HeartSciences Inc (HSCS) Risk Assessment: Volatility, Financial Risk & Investment Risk - TradingKey
HSCS|HeartSciences Inc|Price:2.500|Chg%:+0.110 - TradingKey
HeartSciences files its FY26 annual report on Form 10-K - Medical Buyer
HeartSciences Files 10-K, Highlights Fortitude Mining Deal - The Globe and Mail
HeartSciences Inc. (HSCS) stock price, news, quote and history - Yahoo Finance UK
HeartSciences Files Fiscal 2026 Annual Report and Announces Transformative Merger with Fortitude Mining Holdings - Minichart
HeartSciences Inc (HSCS) Financial Health: Profitability & Balance Sheet Analysis - TradingKey
HeartSciences Inc. (HSCS) Stock Price, News, Quote & History - Yahoo! Finance Canada
HeartSciences Files Its Fiscal 2026 Annual Report on Form 10-K - The Manila Times
HeartSciences (HSCS) highlights Fortitude mining merger plans and new 10-K - Stock Titan
HeartSciences Expects Fiscal 2026 Earnings Release Early Next Week - Stock Titan
HeartSciences Inc. FY 2026: Revenue $4.3K, EPS $(3.48) — 10-K Summary - TradingView
Going concern and Nasdaq listing risks at HeartSciences (Nasdaq: HSCS) - Stock Titan
HeartSciences Inc. Reports Earnings Results for the Full Year Ended April 30, 2026 - marketscreener.com
HSCS Stock Price and Chart — NASDAQ:HSCS - TradingView
HeartSciences Inc. Auditor Raises 'Going Concern' Doubt - marketscreener.com
HeartSciences Inc. Q2 2026 Earnings: EPS Beat Amid Pre-Revenue Stage; Stock Declines 2.73%Profitability Analysis - dars.gov.et
HSCS Q4'25 Earnings: revenue estimate is 0 USD - TradingView
Fortitude and HeartSciences in Merger to Create Publicly Traded Zcash Venture Mining Platform - Global Legal Chronicle
HeartSciences Amends CFO Compensation Amid Fortitude Merger - TipRanks
HeartSciences (NASDAQ: HSCS) ties CFO severance and 25,000 RSUs to Fortitude merger - Stock Titan
HeartSciences (HSCS) Proxy filing Summary - Quartr
Form DEFA14AAdditional definitive proxy soliciting materials and Rule 14(a)(12) material - ADVFN
Form 4 Heart Test Laboratories Inc Unit For: 9 July By Investing.com - Investing.com Nigeria
HeartSciences (HSCS) awards 25,000 contingent RSUs to officer tied to merger vesting - Stock Titan
HeartSciences Inc (HSCS) Earnings Forecast: Future EPS & Revenue Growth Estimates - TradingKey
Price to earnings forward of HeartSciences Inc. – BOATS:HSCSW - TradingView
Price to sales forward of HeartSciences Inc. – NASDAQ:HSCS - TradingView
Price to earnings forward of HeartSciences Inc. – NASDAQ:HSCS - TradingView
Number of shareholders of HeartSciences Inc. – NASDAQ:HSCS - TradingView
Price to book forward of HeartSciences Inc. – NASDAQ:HSCS - TradingView
Enterprise value to revenue forward of HeartSciences Inc. – NASDAQ:HSCS - TradingView
HeartSciences Inc. (HSCS) Q2 2026 Earnings: EPS Beat Amid Pre-Revenue Stage and Continued LossesQuarterly Profit Report - dars.gov.et
Enterprise value to EBIT forward of HeartSciences Inc. – NASDAQ:HSCSW - TradingView
HeartSciences Inc. Warrant 2022- on Heart Test Lab Rg Financial Disclosures & SEC Filings - TradingView
HSCS Q2 2026 Earnings: EPS Surprise Drives Double-Digit Stock RallyManagement Guidance Update - DonanımHaber
HeartSciences Inc. (HSCS) Q2 2026 Earnings: EPS Surprise Drives Double-Digit Stock Rally Amid Pre-Revenue ProgressEarnings Preview - dars.gov.et
HSCS Q1 2026 Earnings: EPS Surprises Positively as Pre-Revenue Company Narrows LossEarnings Forecast Report - DonanımHaber
HeartSciences Inc. (HSCS) Stock Price | Live Quotes & Charts | NASDAQ - StocksToTrade
HSCS News | HEARTSCIENCES INC (NASDAQ:HSCS) - ChartMill
Finanzdaten der Heartsciences Inc-Aktie (HSCS)
Umsatz
Nettogewinn
Free Cashflow
ENV
In Yahoo öffnen
|
In Google öffnen
|
In Finviz öffnen
|
In MarketWatch öffnen
|
Öffnen Sie in EDGAR
|
Offen in Reuters
Kapitalisierung:
|
Volumen (24h):